製薬会社様向け

Articles originally published by the National Center for Biotechnology Information and published by Milliman Insight.

Health Economics & Outcome Research

• Comparison of zonisamide with non-levodopa, anti-Parkinson's disease drugs in the incidence of Parkinson's disease-relevant symptoms.
• Persistence of oral antidiabetic treatment for type 2 diabetes characterized by drug class, patient characteristics and severity of renal impairment: A Japanese database analysis

Real World Evidenceの創出

• Comparison of zonisamide with non-levodopa, anti-Parkinson's disease drugs in the incidence of Parkinson's disease-relevant symptoms.
• Persistence of oral antidiabetic treatment for type 2 diabetes characterized by drug class, patient characteristics and severity of renal impairment: A Japanese database analysis.
• Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database.

上市前薬剤のライセンス評価・ポートフォリオ管理

• Projection of share over time after launch using machine learning and RWD, and its utilization.

新規ヘルスケア事業の戦略立案

• Will a proposed policy in Japan, Health Gold License, work?: Estimation of medical cost saved by medical check-ups.
• Projection of share over time after launch using machine learning and RWD, and its utilization.
• Does health business pay off as an investment?

モデリング・シミュレーションによる意思決定支援

• Diagnostic accuracy of 3D deep-learning-based fully automated estimation of patient-level minimum fractional flow reserve from coronary computed tomography angiography.
• Medical claim cost impact of improved diabetes control for medicare and commercially insured patients with type 2 diabetes.
• Association Between Class if Antidiabetic Drug And Incidence of Myocardial Infarction In Patients with Type 2 Diabetes Melitus: A Proportional Hazard Analysis Using Deep Learning For Risk Adjustment.
• Comparison of medicines after risk adjustments for patients with type-2 diabetes in US health insurance claims data using machine learning of cardiac infarction occurrence rate.
• Development of a predictive model of hemoglobin A1C based on statistical machine learning using clinical data.
• Life insurance risks: Observations on Solvency II and the modeling of capital needs
• Test calculation of effect of promotion of early detection and early treatment of type-C hepatitis virus infection.
• Effect on medical cost reduction of recommendation of visit of doctors for hypertensive individuals who have not visited doctors.
• Effect on medical cost reduction of recommendation of visit of doctors for individuals with diabetes who have not visited doctors.